We used a pooled sample comprised of an unrelated normal breast, and individual TNBC, ER+, and HER2+ tumor tissues to generate a standard curve for assaying JAK2, PD-L1 and PD-L2 expression in our TNBC cohort. The gene discussed is PDCD1LG2; the disease is neoplasm.